ICEPHARMA A/S: Financial statements 2019
CVR: 36393459
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,925,725 and a net result of DKK -7,690,041 compared with DKK -7,235,141 the year before. Equity in the 2019 report amounted to DKK 580,815. The solvency ratio was 33.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -3,925,725
- Profit/Loss
- DKK -7,690,041
- Equity
- DKK 580,815
- Total Assets
- DKK 1,751,025
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3.9 mio. | -7.7 mio. | 581 t. | 5 |
| 2018 | - | -3.6 mio. | -7.2 mio. | 829 t. | 5 |
| 2017 | - | -722 t. | -4.8 mio. | -579 t. | 6 |
| 2016 | - | 2.2 mio. | -3.8 mio. | 188 t. | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ICEPHARMA A/S has published its annual report for 2018. Gross profit came to DKK -3,628,386, and the net result was DKK -7,235,141.
About ICEPHARMA A/S
ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.